Background Image
Table of Contents Table of Contents
Previous Page  54 / 72 Next Page
Information
Show Menu
Previous Page 54 / 72 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016

108

AFRICA

pressure and a reduction in the requirement for treatment at

this point in the pregnancy. As the volume expansion during

pregnancy continues and peaks at about 32 weeks’ gestation, the

need for treatment may increase again. The goals of treatment

also may need to be revised during pregnancy.

Outside pregnancy, the aim of treatment is prevention of

end-organ damage to the heart, vasculature and kidneys. The

use of diuretics with ACE inhibitors is common and the goal of

therapy is normotensive blood pressure. This strategy does not

apply during pregnancy because the drugs may harm the foetus,

and placental perfusion (in theory) may be adversely affected by

antihypertensive drugs that diminish perfusion pressure.

Diuretics, although used to treat cardiac conditions during

pregnancy, are generally held to be contra-indicated in the

management of chronic hypertension during pregnancy

because pregnancy relies upon volume expansion to secure

an accelerated rate of delivery of oxygenated blood to the

peripheral tissues, including the placental bed. ACE inhibitors

are also contra-indicated because they may interfere with the

physiological regulation of uterine blood flow through local

uterine mechanisms. More seriously, they are associated with

neonatal renal failure in children of women treated with them

during pregnancy. Of the other categories of antihypertensive

drugs, beta-blockers are also relatively contra-indicated, being

considered to be an independent risk factor for the development

of intra-uterine growth restriction.

54

Antihypertensive therapy during pregnancy in chronically

hypertensive women is usually secured through the use of alpha-

methyldopa or calcium channel blockers. The aim of treatment

is to reduce the occurrence of severe hypertension to safer levels

of blood pressure. Practically, the threshold for introducing

treatment is a sustained increase in blood pressure to above

160/110 mmHg to levels below this without seeking to reduce the

pressure to normotensive levels.

The complications of chronic hypertension during pregnancy

may extend to various forms of cardiac decompensation,

depending on the severity of the condition. Hence, hypertensive

cardiomyopathy is rarely seen in relatively young women with

chronic hypertension, although it may develop and can give rise

to maternal mortality.

55

More commonly, diastolic dysfunction

caused by changes in left ventricular morphology may result

in the onset of increasing dyspnoea in the third trimester as

the volume expansion peaks out. Patients in this category are

otherwise well, without any signs of superimposed pre-eclampsia.

This is one circumstance where diuretic therapy may result in

rapid clinical improvement and resolution of symptoms that will

allow the pregnancy to continue to term.

Obstetric intervention is not commonly required in chronically

hypertensive women. However, some mild degree of foetal

growth restriction may be present and the risk of superimposed

pre-eclampsia cannot be excluded with absolute certainty.

Consequently, induction of labour is usually recommended

for women who do not labour spontaneously before 40 weeks’

gestation.

Latent hypertension

Pregnancy may render overt hypertension that is not yet clinically

manifest outside of pregnancy. Women who have a strong familial

history of hypertension, whose genetic predisposition will manifest

as essential hypertension in later life, may become hypertensive

during pregnancy. The mechanism is thought to be related to

subnormal pregnancy vasodilatation in vessels, with a hereditary

defect in vasoregulation. In this circumstance, the increased

intravascular volume of pregnancy cannot be accommodated by

adequate vasodilatation, with a rise in blood pressure developing

in the late second to third trimester of pregnancy.

56

This condition should be managed according to the same

principles as those outlined for women with chronic hypertension.

The outcome of the pregnancy is usually unaffected and the

only consideration might be the need for induction of labour in

women not yet delivered by 40 weeks’ gestation.

Physiological hypertension

Hypertension does not always indicate disease. Pregnancy is

characterised by massive plasma volume expansion, and the

cardiovascular adaptation needed to accommodate this increased

intravascular volume is that of equally massive peripheral

vasodilatation. The net consequence of this is a fall in blood

pressure during the second trimester, with increasing levels

of blood pressure closer to term. The entire adaptation is

mediated by the placenta, and the adequacy of the pregnant

physiological change depends on the amount of biochemically

active trophoblast in the uterus. Hence women with multiple

pregnancies or those who have singleton pregnancies with a

large placenta will have a greater degree of volume expansion

than those with a smaller placental mass. The consequences of

this may be a supraphysiological increase in plasma volume that

exceeds the degree of compensatory vasodilatation close to term.

These individuals have normal pregnancies in every respect, with

normally grown babies and no other signs of pre-eclampsia. This

is not a condition requiring treatment or intervention and should

be recognised as a variant of normal.

3

The difficulty of managing these patients lies in being certain

that the distinction can be safely made between physiological

hypertension and pre-eclampsia. For this reason, many of these

women would be allowed to continue to term but induction of

labour would be justified at 40 weeks’ gestation

General evaluation of patients with hyperten-

sive disorder of pregnancy

Determining whether high blood pressure identified during

pregnancy is due to pre-eclampsia or chronic hypertension is

sometimes a challenge to the physician, especially if there are

no recorded blood pressures available from the first half of

the gestation. Clinical characteristics obtained through a good

history, physical examination and some laboratory investigations

may be used to help clarify the diagnosis.

Relevant history the physician must take

The time of detection of hypertension is very important.

Hypertension occurring before 20 weeks’ gestation is

almost always due to chronic hypertension, while new-onset

hypertension after 20 weeks’ gestation should lead to a suspicion

of gestational hypertension. Worsening hypertension after 20

weeks of gestation should lead to careful evaluation for the

manifestations of pre-eclampsia.